These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7695317)

  • 21. Treatment of Helicobacter pylori infection: a review of the world literature.
    van der Hulst RW; Keller JJ; Rauws EA; Tytgat GN
    Helicobacter; 1996 Mar; 1(1):6-19. PubMed ID: 9398908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for
    Kim SJ; Chung JW; Woo HS; Kim SY; Kim JH; Kim YJ; Kim KO; Kwon KA; Park DK
    World J Gastroenterol; 2019 Dec; 25(46):6790-6798. PubMed ID: 31857780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
    Graham DY; Lee SY
    Gastroenterol Clin North Am; 2015 Sep; 44(3):537-63. PubMed ID: 26314667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule.
    de Boer WA
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1559-66. PubMed ID: 11772270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.
    De Francesco V; Zullo A; Fiorini G; Saracino IM; Pavoni M; Vaira D
    J Antimicrob Chemother; 2019 Mar; 74(3):772-774. PubMed ID: 30476134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
    BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: A prospective clinical trial of first-line and rescue therapies.
    Luo L; Huang Y; Liang X; Ji Y; Yu L; Lu H
    Helicobacter; 2020 Aug; 25(4):e12699. PubMed ID: 32428369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
    Lee JW; Kim N; Nam RH; Lee SM; Soo In C; Kim JM; Lee DH
    J Gastroenterol Hepatol; 2019 Apr; 34(4):666-672. PubMed ID: 30726563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of Helicobacter pylori to metronidazole.
    Bateson MC; Winn G; Ahmad F
    Eur J Cancer Prev; 1997 Jun; 6(3):300-2. PubMed ID: 9306078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
    J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
    Isakov V; Domareva I; Koudryavtseva L; Maev I; Ganskaya Z
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1277-82. PubMed ID: 12144577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori.
    Xia H; Keane CT; Beattie S; O'Morain CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2357-61. PubMed ID: 7840570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
    Savarino V; Zentilin P; Pivari M; Bisso G; Raffaella Mele M; Bilardi C; Borro P; Dulbecco P; Tessieri L; Mansi C; Borgonovo G; De Salvo L; Vigneri S
    Aliment Pharmacol Ther; 2000 Jul; 14(7):893-900. PubMed ID: 10886045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.